Intervention Review

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease

  1. Paolo Bongioanni1,*,
  2. Camilla Reali2,
  3. Valeria Sogos2

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 19 JUL 2004

Assessed as up-to-date: 19 APR 2011

DOI: 10.1002/14651858.CD004302.pub2


How to Cite

Bongioanni P, Reali C, Sogos V. Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004302. DOI: 10.1002/14651858.CD004302.pub2.

Author Information

  1. 1

    University of Pisa, Neurorehabilitation Unit, Neuromuscular Disease Section, Department of Neuroscience, Pisa, Italy

  2. 2

    University of Cagliari, Department of Cytomorphology, Monserrato, Cagliari, Italy

*Paolo Bongioanni, Neurorehabilitation Unit, Neuromuscular Disease Section, Department of Neuroscience, University of Pisa, Via Paradisa, 2, Pisa, 56100, Italy. paolo.bongioanni@tin.it. p.bongioanni@ao-pisa.toscana.it.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 19 JUL 2004

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.